Evidence map›Paper›PMID 40008433›Full record

ArticleHypertension (Dallas, Tex. : 1979)2025

Hypertension Prevention and Healthy Life Expectancy in Black Adults: The Jackson Heart Study.

Kathryn Foti, Yiyi Zhang, Susan E Hennessy, Lisandro D Colantonio, Lama Ghazi, Shakia T Hardy, Milla E Arabadjian, Rushelle L Byfield, Valy Fontil, Cora E Lewis and 3 more

Abstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kathryn FotiDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0002-6380-2735
Yiyi ZhangDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0002-8663-5001
Susan E HennessyDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0002-6342-7138
Lisandro D ColantonioDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0001-8742-1788
Lama GhaziDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0002-9930-3575
Shakia T HardyDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0001-9211-0474
Milla E ArabadjianDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0003-3307-1406
Rushelle L ByfieldDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0002-4673-7118
Valy FontilDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0003-0795-3237
Cora E LewisDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0002-2301-5796
Daichi ShimboDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0001-6302-8834
Paul MuntnerDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0002-4711-5492
Brandon K BellowsDepartment of Epidemiology, University of Alabama at Birmingham School of Public Health, AL (K.F., L.D.C., L.G., C.E.L., P.M.).ORCID 0000-0003-1395-6047

Funding

Institutional Career Development CoreKL2TR001874 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GENKINGER, JEANINE M., SHIMBO, DAICHI · 2016 to 2025
$13.6M
Incorporation of a Hypertension Working Group into the Jackson Heart StudyR01HL117323 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEWIS, CORA E, OGEDEGBE, OLUGBENGA G. · 2013 to 2024
$7.2M
Improving Blood Pressure Screening and Treatment Strategies in Young AdultsR01HL158790 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI AN, JAEJIN, ZHANG, YIYI · 2021 to 2025
$3.5M
Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of lifeR01AG074989 · NIA · UNIVERSITY OF PENNSYLVANIA · PI BRESS, ADAM P, COHEN, JORDANA B. · 2022 to 2025
$3.3M
Comparing the value of intensive systolic blood pressure treatment implementation strategiesK01HL140170 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BELLOWS, BRANDON K · 2018 to 2022
$709k
American Heart Association-American Stroke Association 878088NCATS NIH HHS KL2 TR001874NHLBI NIH HHS HHSN268201800010INHLBI NIH HHS HHSN268201800011CNHLBI NIH HHS HHSN268201800011INHLBI NIH HHS HHSN268201800012CNHLBI NIH HHS HHSN268201800012INHLBI NIH HHS HHSN268201800014CNHLBI NIH HHS HHSN268201800014INHLBI NIH HHS HHSN268201800015INHLBI NIH HHS K01 HL140170NHLBI NIH HHS R01 HL117323NHLBI NIH HHS R01 HL158790NIA NIH HHS R01 AG074989NIMHD NIH HHS HHSN268201800013I
6 · The paper itself

Abstract

backgroundThe impact of preventing hypertension and maintaining normal blood pressure (BP) on life expectancy and healthy life expectancy (HLE) among Black adults, who are disproportionately affected by hypertension, has not been quantified.

methodsWe used a discrete event simulation to estimate life expectancy and HLE among a cohort of Black adults from the Jackson Heart Study (n=4933) from age 20 to 100 years or until death. We modeled preventing hypertension as having BP <130/80 mm Hg and maintaining normal BP as having BP <120/80 mm Hg across the lifespan. In the primary analysis, we assumed that lowering BP decreased the risk of cardiovascular disease events, resulting in life expectancy and HLE gains. In a secondary analysis, we assumed that preventing hypertension and maintaining normal BP directly reduced both cardiovascular disease and mortality risk.

resultsAt age 20 years, the projected average life expectancy was age 80.8 (95% uncertainty interval [UI], 80.6-81.1) years, and HLE was 70.5 (95% UI, 70.3-70.7) healthy life years. In the primary analysis, preventing hypertension and maintaining normal BP added 0.9 (95% UI, 0.8-1.1) and 1.1 (95% UI, 0.9-1.3) years to life expectancy, respectively, and 2.7 (95% UI, 2.6-2.9) and 2.9 (95% UI, 2.7-3.1) healthy life years to HLE, respectively. In the secondary analysis, preventing hypertension and maintaining normal BP added 4.5 (95% UI, 4.3-4.6) and 4.6 (95% UI, 4.4-4.8) years to life expectancy, respectively, and 5.7 (95% UI, 5.6-5.8) and 5.9 (95% UI, 5.7-6.0) healthy life years to HLE, respectively.

conclusionsPreventing hypertension and maintaining normal BP were projected to increase life expectancy and HLE among Black adults.

Indexed as

Black or African AmericanHypertensionLife ExpectancyAdultAgedAged, 80 and overBlood PressureCardiovascular DiseasesCohort StudiesFemaleHumansMaleMiddle AgedMississippiYoung Adultblood pressurehealthy life expectancyhypertensionlife expectancy

Identifiers

PMID40008433
PMCPMC12078003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.